Lansik’s AI-Based Blood Sugar Solution Glucofit Secures KRW 1.2 Billion in Pre-Series A Funding
Lansik, the operator of South Korea's AI blood sugar management solution 'Glucofit,' has raised KRW 1.2 billion in pre-Series A funding....
Lansik, the operator of South Korea's AI blood sugar management solution 'Glucofit,' has raised KRW 1.2 billion in pre-Series A funding....
InfoBank's investment division, iAccel, based in Korea, has announced its annual investment performance and achievements for 2023. In the past year,...
Korean biotech company GeneCraft has successfully closed a Series A funding round, raising KRW 10 billion. Key investors include Seoul Techno...
Business Canvas, the South Korea-based operator of Typed, a document collaboration tool, today announced that it has closed its Series A2...